Drug price control in India - an ongoing debate
By: Narayanan, Krithiga
.
Material type: 
BookPublisher: Economic and Political Weekly Description: 57(50), Dec, 10, 2022: p.17-20.
In:
Economic and Political WeeklySummary: Price control of life-saving essential medicines is the need of the hour, but the National Pharmaceutical Pricing Authority has allowed a hike of 10% in nearly 800 drugs and devices listed under the National List of Essential Medicines from 1 April 2022 because of the rising input costs. Prices of scheduled drugs are allowed an increase each year acc¬ording to the wholesale price index. Input costs are rising primarily because India is heavily dependent on China for drug imports.- Reproduced
| Item type | Current location | Call number | Vol info | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
Articles
|
Indian Institute of Public Administration | 50(57), Dec, 10, 2022: p.17-20 | Available | AR128115 |
Price control of life-saving essential medicines is the need of the hour, but the National Pharmaceutical Pricing Authority has allowed a hike of 10% in nearly 800 drugs and devices listed under the National List of Essential Medicines from 1 April 2022 because of the rising input costs. Prices of scheduled drugs are allowed an increase each year acc¬ording to the wholesale price index. Input costs are rising primarily because India is heavily dependent on China for drug imports.- Reproduced
There are no comments for this item.